Sphingosine-1-Phosphate Receptor 4 Attenuates Neutrophilic Airway Inflammation in Experimental Asthma via Repressing Proinflammatory Macrophage Activation

Patients with eosinophilic asthma react well to conventional treatment of asthma while individualized therapy for non-eosinophilic endotypes have yet to be developed. Dysregulated sphingosine metabolites are associated with the pathophysiology of different asthma endotypes with their receptors invol...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shanshan, Tian, Zhen, Lu, Yanjiao, Huang, Zhenli, Fan, Yan, Li, Boyu, Zheng, Hongyan, Wu, Xiaojie, Wang, Meijia, Zhao, Jianping, Xie, Jungang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086758/
https://www.ncbi.nlm.nih.gov/pubmed/37056936
http://dx.doi.org/10.7150/ijbs.80256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086758/
https://www.ncbi.nlm.nih.gov/pubmed/37056936
http://dx.doi.org/10.7150/ijbs.80256

Ejemplares similares